Lapice Emanuela, Maione Simona, Patti Lidia, Cipriano Paola, Rivellese Angela A, Riccardi Gabriele, Vaccaro Olga
Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy.
Diabetes Care. 2009 Sep;32(9):1734-6. doi: 10.2337/dc09-0176. Epub 2009 Jul 8.
There is debate over the most appropriate adiposity markers of obesity-associated health risks. We evaluated the relationship between fat distribution and high-sensitivity C-reactive protein (hs-CRP), independent of total adiposity.
We studied 350 people with abdominal adiposity (waist-to-hip ratio [WHR] > or =0.9 in male and > or =0.85 in female subjects) and 199 control subjects (WHR <0.9 in male and <0.85 in female subjects) matched for BMI and age. We measured hs-CRP and major cardiovascular risk factors.
Participants with abdominal adiposity had BMI similar to that in control subjects (24.8 +/- 2.5 vs. 24.7 +/- 2.2 kg/m(2), respectively), but significantly higher waist circumference (96.4 +/- 6.0 vs. 83.3 +/- 6.7 cm; P < 0.01) and WHR (1.07 +/- 0.08 vs. 0.85 +/- 0.05; P < 0.001). Compared with the control subjects, participants with abdominal adiposity had an adverse cardiovascular risk factor profile, significantly higher hs-CRP (1.96 +/- 2.60 vs. 1.53 +/- 1.74 mg/dl; P < 0.01), and a twofold prevalence of elevated CRP values (>3 mg/dl).
In nonobese people, moderate abdominal adiposity is associated with markers of subclinical inflammation independent of BMI.
关于肥胖相关健康风险最适宜的肥胖指标存在争议。我们评估了脂肪分布与高敏C反应蛋白(hs-CRP)之间的关系,且不考虑总体肥胖情况。
我们研究了350例腹部肥胖者(男性腰臀比[WHR]≥0.9,女性≥0.85)以及199例对照者(男性WHR<0.9,女性<0.85),这些对照者在体重指数(BMI)和年龄方面与腹部肥胖者相匹配。我们测量了hs-CRP及主要心血管危险因素。
腹部肥胖参与者的BMI与对照者相似(分别为24.8±2.5和24.7±2.2kg/m²),但腰围显著更高(96.4±6.0对83.3±6.7cm;P<0.01),WHR也显著更高(1.07±0.08对0.85±0.05;P<0.001)。与对照者相比,腹部肥胖参与者具有不良的心血管危险因素谱,hs-CRP显著更高(1.96±2.60对1.53±1.74mg/dl;P<0.01),且CRP值升高(>3mg/dl)的患病率为对照者的两倍。
在非肥胖人群中,中度腹部肥胖与亚临床炎症指标相关,且独立于BMI。